US Bancorp’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.62K | Sell |
230
-12
| -5% | -$137 | ﹤0.01% | 3806 |
|
|
2025
Q1 | $2.88K | Sell |
242
-1,182
| -83% | -$14K | ﹤0.01% | 3781 |
|
|
2024
Q4 | $26.8K | Buy |
1,424
+842
| +145% | +$15.9K | ﹤0.01% | 3029 |
|
|
2024
Q3 | $13.1K | Sell |
582
-650
| -53% | -$14.6K | ﹤0.01% | 3261 |
|
|
2024
Q2 | $25.7K | Buy |
1,232
+928
| +305% | +$19.4K | ﹤0.01% | 2954 |
|
|
2024
Q1 | $4.47K | Buy |
304
+230
| +311% | +$3.38K | ﹤0.01% | 3541 |
|
|
2023
Q4 | $764 | Sell |
74
-113
| -60% | -$1.17K | ﹤0.01% | 3807 |
|
|
2023
Q3 | $1.47K | Sell |
187
-640
| -77% | -$5.03K | ﹤0.01% | 3689 |
|
|
2023
Q2 | $8.26K | Buy |
827
+8
| +1% | +$80 | ﹤0.01% | 3301 |
|
|
2023
Q1 | $7.27K | Buy |
819
+716
| +695% | +$6.36K | ﹤0.01% | 3384 |
|
|
2022
Q4 | $1.13K | Sell |
103
-166
| -62% | -$1.82K | ﹤0.01% | 3880 |
|
|
2022
Q3 | $4K | Buy |
269
+195
| +264% | +$2.9K | ﹤0.01% | 3655 |
|
|
2022
Q2 | $1K | Hold |
74
| – | – | ﹤0.01% | 3953 |
|
|
2022
Q1 | $1K | Sell |
74
-52
| -41% | -$703 | ﹤0.01% | 3932 |
|
|
2021
Q4 | $4K | Buy |
126
+74
| +142% | +$2.35K | ﹤0.01% | 3701 |
|
|
2021
Q3 | $2K | Sell |
52
-109
| -68% | -$4.19K | ﹤0.01% | 3861 |
|
|
2021
Q2 | $4K | Buy |
161
+153
| +1,913% | +$3.8K | ﹤0.01% | 3646 |
|
|
2021
Q1 | $0 | Buy |
+8
| New | – | ﹤0.01% | 3895 |
|